TW202408472A - 眼科組成物 - Google Patents

眼科組成物 Download PDF

Info

Publication number
TW202408472A
TW202408472A TW112125144A TW112125144A TW202408472A TW 202408472 A TW202408472 A TW 202408472A TW 112125144 A TW112125144 A TW 112125144A TW 112125144 A TW112125144 A TW 112125144A TW 202408472 A TW202408472 A TW 202408472A
Authority
TW
Taiwan
Prior art keywords
ophthalmic composition
salts
container
tramadol
acid
Prior art date
Application number
TW112125144A
Other languages
English (en)
Chinese (zh)
Inventor
小川庸子
北澤昭太
Original Assignee
日商樂敦製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商樂敦製藥股份有限公司 filed Critical 日商樂敦製藥股份有限公司
Publication of TW202408472A publication Critical patent/TW202408472A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
TW112125144A 2022-07-06 2023-07-05 眼科組成物 TW202408472A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022-109256 2022-07-06
JP2022109256 2022-07-06

Publications (1)

Publication Number Publication Date
TW202408472A true TW202408472A (zh) 2024-03-01

Family

ID=89453486

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112125144A TW202408472A (zh) 2022-07-06 2023-07-05 眼科組成物

Country Status (7)

Country Link
US (1) US20250381154A1 (cg-RX-API-DMAC7.html)
EP (1) EP4534081A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2024010039A1 (cg-RX-API-DMAC7.html)
KR (1) KR20250030490A (cg-RX-API-DMAC7.html)
CN (1) CN119451669A (cg-RX-API-DMAC7.html)
TW (1) TW202408472A (cg-RX-API-DMAC7.html)
WO (1) WO2024010039A1 (cg-RX-API-DMAC7.html)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017963A (en) * 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
SG170044A1 (en) * 2006-03-31 2011-04-29 Vistakon Pharmaceuticals Llc Ocular allergy treatments
EP2694048B1 (en) * 2011-04-05 2020-10-07 Optosolve Research & Development Ltd Ophthalmic treatments
ES2604816B1 (es) * 2015-09-09 2018-01-29 Farmalider, S.A. Composición farmacéutica de tramadol para uso oftálmico
KR20200035047A (ko) * 2017-08-03 2020-04-01 산텐 세이야꾸 가부시키가이샤 클로르헥시딘을 함유하는 의약 조성물
JP6855632B1 (ja) * 2020-02-19 2021-04-07 千寿製薬株式会社 医薬製品

Also Published As

Publication number Publication date
WO2024010039A1 (ja) 2024-01-11
KR20250030490A (ko) 2025-03-05
EP4534081A1 (en) 2025-04-09
CN119451669A (zh) 2025-02-14
EP4534081A4 (en) 2026-05-20
US20250381154A1 (en) 2025-12-18
JPWO2024010039A1 (cg-RX-API-DMAC7.html) 2024-01-11

Similar Documents

Publication Publication Date Title
ES2901140T3 (es) Composiciones farmacéuticas de atropina
TWI874894B (zh) 含阿托平之水性組成物
JP6178028B1 (ja) ドルゾラミドとチモロールと界面活性剤を含有する医薬組成物
JPWO2019026992A1 (ja) クロルヘキシジンを含有する医薬組成物
TWI888462B (zh) 水性組成物
TWI889740B (zh) 水性組成物
TW202408467A (zh) 眼科組成物
WO2024160252A1 (zh) 一种低浓度的阿托品药物产品及其制造方法
US20240216323A1 (en) Topical formulations of chloroprocaine and methods of using same
TW202408468A (zh) 眼科組成物
WO2024010039A1 (ja) 眼科組成物
HK40115731A (en) Ophthalmic composition
JP2023030691A (ja) 眼科組成物
JP2000506182A (ja) 液―ゲル相転移を起こすタイプの点眼剤組成物
WO2025146828A1 (ja) 眼科組成物
HK40115979A (en) Ophthalmic composition
TW202448475A (zh) 眼科組成物
EP4534082A1 (en) Ophthalmic composition
TW202444342A (zh) 水性組成物
BR112019023515B1 (pt) Composição oftálmica de atropina líquida de baixa dosagem, estável em armazenamento, método para aumentar a estabilidade de armazenamento de atropina em dita composição, kit de tratamento para tratamento de miopia e uso de dita composição